BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 7272583)

  • 1. Antagonism of opiate mydriasis in mice.
    Korczyn AD; Rock M
    Br J Pharmacol; 1981 Aug; 73(4):807-10. PubMed ID: 7272583
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The human pharmacology and abuse potential of N-allylnoroxymorphone (naloxone).
    Jasinski DR; Martin WR; Haertzen CA
    J Pharmacol Exp Ther; 1967 Aug; 157(2):420-6. PubMed ID: 6039832
    [No Abstract]   [Full Text] [Related]  

  • 3. Relative ability of N-methyl nalorphine and N-methyl levallorphan to prevent antinociception and intestinal transit inhibition in morphine treated rats.
    Notarnicola A; Landi M; Bianchi G; Tavani A
    Life Sci; 1983; 33 Suppl 1():481-4. PubMed ID: 6664229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The specificity of the pupillary actions of morphine and naloxone.
    Rabinowitz R; Korczyn AD
    J Ocul Pharmacol; 1987; 3(1):17-21. PubMed ID: 3503906
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assays for narcotic antagonist activity in rodents.
    Pierson AK
    Adv Biochem Psychopharmacol; 1973; 8(0):245-61. PubMed ID: 4152786
    [No Abstract]   [Full Text] [Related]  

  • 6. Modification of the analgesic action of pethidine and morphine by three opiate antagonists, a respiratory stimulant (doxapram) and an analeptic (nikethamide); a study using an experimental pain stimulus in man.
    Dundee JW; Gupta PK; Jones CJ
    Br J Pharmacol; 1973 Jun; 48(2):326P. PubMed ID: 4733735
    [No Abstract]   [Full Text] [Related]  

  • 7. Homobenzomorphan compounds with a potent narcotic antagonist property.
    Nurimoto S; Suzuki S; Hayashi G; Takeda M
    Jpn J Pharmacol; 1974 Jun; 24(3):461-9. PubMed ID: 4449151
    [No Abstract]   [Full Text] [Related]  

  • 8. Morphine-induced mydriasis and fluctuation in the rat: time and dose relationships.
    Klemfuss H; Tallarida RJ; Adler CH; Adler MW
    J Pharmacol Exp Ther; 1979 Jan; 208(1):91-5. PubMed ID: 759618
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Narcotic antagonist activity of substituted 1,2,4,5-tetrahydro-3H,3-benzazepines.
    Giering JE; Davidson TA; Shetty BV; Truant AP
    Adv Biochem Psychopharmacol; 1973; 8(0):167-86. PubMed ID: 4800174
    [No Abstract]   [Full Text] [Related]  

  • 10. Counteraction of narcotic antagonist analgesics by the narcotic antagonist Naloxone.
    Blumberg H; Dayton HB; Wolf PS
    Proc Soc Exp Biol Med; 1966 Dec; 123(3):755-8. PubMed ID: 4381176
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative study of the action of naloxone (Narcan) and nalorphine in man.
    Aronski A; Kübler A; Majda A; Jakubaszko J
    Anaesth Resusc Intensive Ther; 1975; 3(3):221-30. PubMed ID: 1217693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antagonism by N-methyl levallorphan-methane sulphonate (SR 58002 C) of morphine-elicited acute and chronic central and peripheral effects.
    Sbacchi M; Colombo M; La Regina A; Petrillo P; Tavani A
    Life Sci; 1988; 42(21):2079-89. PubMed ID: 3386393
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Levallorphan methyl iodide (SR 58002), a potent narcotic antagonist with peripheral selectivity superior to that of other quaternary compounds.
    Dragonetti M; Bianchetti A; Sacilotto R; Giudice A; Ferrarese N; Cattaneo C; Manara L
    Life Sci; 1983; 33 Suppl 1():477-80. PubMed ID: 6664228
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The peripheral narcotic antagonist N-allyl levallorphan-bromide (CM 32191) selectively prevents morphine antipropulsive action and buprenorphine in-vivo binding in the rat intestine.
    Bianchi G; Fiocchi R; Peracchia F; Petrillo P; Tavani A; Manara L
    J Pharm Pharmacol; 1984 May; 36(5):326-30. PubMed ID: 6145770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effects of naloxone and nalorphine during the development of morphine dependence in rhesus monkeys.
    Aceto MD; Flora RE; Harris LS
    Pharmacology; 1977; 15(1):1-9. PubMed ID: 402658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute effects of opiate agonists, partial agonists and antagonists on brain monoamines in the rat.
    Fennessy MR; Laska FJ
    Arch Int Pharmacodyn Ther; 1979 Mar; 238(1):60-70. PubMed ID: 485705
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Opiate agonists and antagonists discriminated by receptor binding in brain.
    Pert CB; Pasternak G; Snyder SH
    Science; 1973 Dec; 182(4119):1359-61. PubMed ID: 4128222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Some behavioral effects of morphine, naloxone and nalorphine in the squirrel monkey and the pigeon.
    Goldberg SR; Morse WH; Goldberg DM
    J Pharmacol Exp Ther; 1976 Mar; 196(3):625-36. PubMed ID: 817014
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assays of antagonistic activity of narcotic antagonists in man.
    Gorodetzky CW
    Adv Biochem Psychopharmacol; 1973; 8(0):291-7. PubMed ID: 4604130
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of narcotic analgesics and antagonists on the in vivo release of acetylcholine from the cerebral cortex of the cat.
    Jhamandas K; Phillis JW; Pinsky C
    Br J Pharmacol; 1971 Sep; 43(1):53-66. PubMed ID: 5136464
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.